US Stock MarketDetailed Quotes

REVB Revelation Biosciences

Watchlist

2.0260
+0.1660+8.92%

Trading May 17 13:40 ET

3.31MMarket Cap-50P/E (TTM)

Revelation Biosciences Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-80.17%-2.84M

35.06%-7.29M

-111.39%-2M

0.85%-1.72M

46.32%-1.99M

67.39%-1.58M

-1.16%-11.22M

67.09%-947.47K

22.52%-1.73M

-3.21%-3.71M

Net income from continuing operations

-143.54%-2.68M

98.89%-120.25K

-82.42%-2.2M

-124.51%-2.63M

21.07%-1.45M

193.09%6.16M

9.65%-10.83M

68.72%-1.21M

61.55%-1.17M

25.71%-1.83M

Operating gains losses

99.12%-68.43K

---8.33M

---68.2K

---92.56K

---423.24K

---7.74M

----

Depreciation and amortization

-0.02%6.26K

0.00%25.05K

0.00%6.26K

0.02%6.26K

49.26%25.05K

0.00%6.26K

3.15%6.26K

64.49%6.26K

Other non cash items

----

-71.44%14.96K

--0

Change In working capital

-355.37%-126.47K

234.36%982.14K

3.80%229.91K

258.96%965.9K

90.57%-185.9K

-101.71%-27.77K

-305.20%-730.97K

-74.08%221.5K

-192.33%-607.62K

-54.74%-1.97M

-Change in prepaid assets

104.94%12.82K

-102.03%-11.56K

-71.27%67.95K

-63.37%97.38K

-24.63%82.38K

-508.52%-259.26K

211.72%569.04K

-74.50%236.5K

121.99%265.85K

107.02%109.3K

-Change in payables and accrued expense

-223.53%-210.41K

174.59%911.62K

205.61%141.05K

199.43%868.52K

87.11%-268.28K

-89.90%170.33K

-233.40%-1.22M

181.88%46.15K

-257.58%-873.47K

-810.13%-2.08M

-Change in other current liabilities

----

--0

----

66.89%-16.75K

--0

-Change in other working capital

16.32%71.13K

234.20%82.07K

--20.92K

--0

--61.15K

---61.15K

----

Cash from discontinued investing activities

Operating cash flow

-80.17%-2.84M

35.06%-7.29M

-111.39%-2M

0.85%-1.72M

46.32%-1.99M

67.39%-1.58M

-1.16%-11.22M

67.09%-947.47K

22.52%-1.73M

-3.21%-3.71M

Investing cash flow

Cash flow from continuing investing activities

-19.17K

Net PPE purchase and sale

---19.17K

----

--0

----

Cash from discontinued investing activities

Investing cash flow

---19.17K

----

--0

----

Financing cash flow

Cash flow from continuing financing activities

-61.37%5.42M

-7.72%14.03M

30.57%14.02M

89.86%15.2M

4.45M

Net issuance payments of debt

----

--0

----

---796.88K

--0

Net common stock issuance

-61.39%5.42M

215.21%14.03M

--0

93.19%14.03M

641.85%4.45M

--0

--4.45M

---7.26M

Net preferred stock issuance

--0

-200.00%-5K

--0

---5K

-99.93%5K

--5K

--0

Proceeds from stock option exercised by employees

568.42%127

-99.33%34

--0

--15

-99.63%19

--5.09K

--0

Net other financing activities

----

--11.53M

--0

--7.26M

Cash from discontinued financing activities

Financing cash flow

-61.37%5.42M

-7.72%14.03M

--0

--15

30.57%14.02M

89.86%15.2M

--5K

--4.45M

--0

Net cash flow

Beginning cash position

128.28%11.99M

312.09%5.25M

125.88%13.99M

352.02%15.71M

146.34%17.7M

312.09%5.25M

-71.62%1.27M

49.74%6.2M

-45.45%3.48M

-28.25%7.19M

Current changes in cash

-79.44%2.56M

69.39%6.74M

-112.51%-2M

-163.12%-1.72M

46.32%-1.99M

110.60%12.45M

223.64%3.98M

67.08%-942.47K

221.70%2.72M

-1.82%-3.71M

End cash Position

-17.80%14.55M

128.28%11.99M

125.88%13.99M

352.02%15.71M

146.34%17.7M

312.09%5.25M

49.74%6.2M

-45.45%3.48M

Free cash flow

-81.39%-2.86M

35.06%-7.29M

-111.39%-2M

0.85%-1.72M

46.32%-1.99M

67.39%-1.58M

0.03%-11.22M

66.90%-947.47K

22.52%-1.73M

-1.82%-3.71M

Currency Unit

USD

Audit Opinions

Unqualified Opinion

Unqualified Opinion with Explanatory Notes

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-80.17%-2.84M	35.06%-7.29M	-111.39%-2M	0.85%-1.72M	46.32%-1.99M	67.39%-1.58M	-1.16%-11.22M	67.09%-947.47K	22.52%-1.73M	-3.21%-3.71M
Net income from continuing operations	-143.54%-2.68M	98.89%-120.25K	-82.42%-2.2M	-124.51%-2.63M	21.07%-1.45M	193.09%6.16M	9.65%-10.83M	68.72%-1.21M	61.55%-1.17M	25.71%-1.83M
Operating gains losses	99.12%-68.43K	---8.33M	---68.2K	---92.56K	---423.24K	---7.74M	----	----	----	----
Depreciation and amortization	-0.02%6.26K	0.00%25.05K	0.00%6.26K	0.00%6.26K	0.00%6.26K	0.02%6.26K	49.26%25.05K	0.00%6.26K	3.15%6.26K	64.49%6.26K
Other non cash items	----	----	----	----	----	----	-71.44%14.96K	--0	--0	--0
Change In working capital	-355.37%-126.47K	234.36%982.14K	3.80%229.91K	258.96%965.9K	90.57%-185.9K	-101.71%-27.77K	-305.20%-730.97K	-74.08%221.5K	-192.33%-607.62K	-54.74%-1.97M
-Change in prepaid assets	104.94%12.82K	-102.03%-11.56K	-71.27%67.95K	-63.37%97.38K	-24.63%82.38K	-508.52%-259.26K	211.72%569.04K	-74.50%236.5K	121.99%265.85K	107.02%109.3K
-Change in payables and accrued expense	-223.53%-210.41K	174.59%911.62K	205.61%141.05K	199.43%868.52K	87.11%-268.28K	-89.90%170.33K	-233.40%-1.22M	181.88%46.15K	-257.58%-873.47K	-810.13%-2.08M
-Change in other current liabilities	----	--0	--0	--0	----	----	66.89%-16.75K	--0	--0	--0
-Change in other working capital	16.32%71.13K	234.20%82.07K	--20.92K	--0	--0	--61.15K	---61.15K	----	----	----
Cash from discontinued investing activities
Operating cash flow	-80.17%-2.84M	35.06%-7.29M	-111.39%-2M	0.85%-1.72M	46.32%-1.99M	67.39%-1.58M	-1.16%-11.22M	67.09%-947.47K	22.52%-1.73M	-3.21%-3.71M
Investing cash flow
Cash flow from continuing investing activities	-19.17K					0
Net PPE purchase and sale	---19.17K	----	----	----	----	--0	----	----	----	----
Cash from discontinued investing activities
Investing cash flow	---19.17K	----	----	----	----	--0	----	----	----	----
Financing cash flow
Cash flow from continuing financing activities	-61.37%5.42M	-7.72%14.03M	0	0	15	30.57%14.02M	89.86%15.2M	5K	4.45M	0
Net issuance payments of debt	----	--0	--0	--0	----	----	---796.88K	--0	--0	--0
Net common stock issuance	-61.39%5.42M	215.21%14.03M	--0	--0	--0	93.19%14.03M	641.85%4.45M	--0	--4.45M	---7.26M
Net preferred stock issuance	--0	-200.00%-5K	--0	--0	--0	---5K	-99.93%5K	--5K	--0	--0
Proceeds from stock option exercised by employees	568.42%127	-99.33%34	--0	--0	--15	-99.63%19	--5.09K	--0	--0	--0
Net other financing activities	----	----	----	----	----	----	--11.53M	--0	--0	--7.26M
Cash from discontinued financing activities
Financing cash flow	-61.37%5.42M	-7.72%14.03M	--0	--0	--15	30.57%14.02M	89.86%15.2M	--5K	--4.45M	--0
Net cash flow
Beginning cash position	128.28%11.99M	312.09%5.25M	125.88%13.99M	352.02%15.71M	146.34%17.7M	312.09%5.25M	-71.62%1.27M	49.74%6.2M	-45.45%3.48M	-28.25%7.19M
Current changes in cash	-79.44%2.56M	69.39%6.74M	-112.51%-2M	-163.12%-1.72M	46.32%-1.99M	110.60%12.45M	223.64%3.98M	67.08%-942.47K	221.70%2.72M	-1.82%-3.71M
End cash Position	-17.80%14.55M	128.28%11.99M	128.28%11.99M	125.88%13.99M	352.02%15.71M	146.34%17.7M	312.09%5.25M	312.09%5.25M	49.74%6.2M	-45.45%3.48M
Free cash flow	-81.39%-2.86M	35.06%-7.29M	-111.39%-2M	0.85%-1.72M	46.32%-1.99M	67.39%-1.58M	0.03%-11.22M	66.90%-947.47K	22.52%-1.73M	-1.82%-3.71M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Audit Opinions	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion with Explanatory Notes	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall